Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables behind every metabolic decision. Browse all Peptides & GLP-1 education
This independent editorial review comes from PlexusDx. We hold no commercial relationship with Medvi, no affiliate links, and take no compensation for its contents.
Anyone comparing GLP-1 programs quickly learns that "price" is really several numbers stacked together: a promotional first month, an ongoing rate, and a bundle discount. This review unpacks how Medvi builds its pricing, what actually drives the monthly figure, and what the number leaves out. Fair-balance framing, current as of April 2026.
How Medvi structures its pricing
Medvi shows pricing only after a short health questionnaire, and the model is promotion-led rather than a flat published rate. Two things shape what you see: which compound you pursue (semaglutide or tirzepatide) and whether you pay month to month or prepay a bundle. Dose does not change the price — the rate is flat across strengths, which simplifies comparison but folds titration into a single number.
The compounded plan price ladder
As captured July 2026, compounded semaglutide runs about $299 per month ongoing after a $159 first-month promotional price; compounded tirzepatide runs about $399 per month ongoing after a $259 first month. A dissolvable GLP-1 tablet is also listed, with its price shown after intake. These figures move frequently, so treat any snapshot as a starting point and confirm live numbers before committing.
Membership versus cash-pay: what’s bundled
The compounded program carries no membership fee and no separate consultation charge — the monthly medication price is the headline cost. Branded Wegovy or Zepbound sit on a different track: a $99 membership plus the cost of the medication itself. That split means the "price" of Medvi depends heavily on whether you choose the compounded or branded route.
What drives the monthly number
Prepayment is the biggest lever. Multi-month prepaid bundles lower the effective monthly rate versus paying month to month, trading a larger upfront charge for a better per-month figure. The compound you choose is the other driver: tirzepatide sits above semaglutide across the board. There is no insurance offset here — this is a cash-pay compounded telehealth model.
Reading the price against clinical value
A monthly rate only means something next to what the compound does. Semaglutide is a GLP-1 receptor agonist; tirzepatide is a GIP/GLP-1 dual agonist. The evidence includes STEP (semaglutide, The New England Journal of Medicine, 2021), SURMOUNT (tirzepatide, NEJM 2022), and SURMOUNT-OSA (NEJM 2024). Populations and endpoints vary; outcomes vary individually. Price is one input among several.
The pricing variable no plan lists — your genetics
Every program prices the compound; none prices the person. Variants in FTO, GLP1R (the GLP-1 receptor these compounds target), MC4R, and TCF7L2 shape the appetite, energy-balance, and glucose biology any GLP-1 acts on. They do not predict response to a specific compound, but they inform the conversation before you spend. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral — paired with the Precision Peptide Genetic Test, which analyzes 14 pathways, 49 peptides, 150+ genetic insights. That is the test before you invest approach.
Not affiliated: PlexusDx has no relationship with Medvi and no commercial tie to the companies named here.
Related reading on PlexusDx: GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1, GLP 1 What Is.
Disclaimer: This article is educational. PlexusDx is not affiliated with Medvi and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols; this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.
Compare approaches: see the Weight Management Protocols, or take the Precision Peptide Genetic Test to understand your GLP-1 pathway first.
Frequently Asked Questions
How does Medvi set its prices?
Pricing appears after a short health questionnaire and is promotion-led rather than flatly published. It varies by compound and by whether you pay monthly or prepay a bundle, but not by dose — the rate is flat across strengths. Figures change often, so confirm current numbers on Medvi’s site.
Does Medvi charge a membership fee?
The compounded semaglutide and tirzepatide program carries no membership fee and no separate consultation charge; the monthly medication price is the whole cost. The branded Wegovy and Zepbound routes are different, adding a $99 membership plus the cost of the medication itself.
Can prepaying lower the monthly price?
Yes. Multi-month prepaid bundles reduce the effective monthly rate compared with paying month to month, in exchange for a larger charge upfront. The trade-off is commitment: you pay more at once for a better per-month figure. This is a cash-pay model with no insurance offset.
How does PlexusDx frame value differently?
Rather than pricing only the compound, PlexusDx pairs its Weight Management Protocols with the Precision Peptide Genetic Test, which maps pathway-level variants in FTO, GLP1R, MC4R, and TCF7L2. The genetic context does not predict drug response but informs the decision before you spend on any protocol.
This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Medvi Legit? Licensing, Compounding, and Oversight
Medvi GLP-1 Review: Menu, Eligibility, and Pricing